Skip to main content
OpenTrials

Clinical trial condition

Sebaceous Gland Diseases

Explore clinical trials studying Sebaceous Gland Diseases. Study availability and eligibility vary by location and protocol.

655 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Sebaceous Gland Diseases trial results

Completed

Efficacy and Safety of CD5024 1% in Acne Vulgaris

NCT03034460

Conditions
Acne, Acne Vulgaris, Acneiform Eruptions, +3 more
Locations
  • Galderma Investigational Site (# 8060) Windsor, Ontario, Canada
  • Galderma Investigational site Montreal, Quebec, Canada
  • Galderma investigational site Nantes, France
  • Galderma investigational site Nice, France
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris

NCT04163263

Conditions
Acne Vulgaris, Acneiform Eruptions, Moderate to Severe Acne Vulgaris, +3 more
Locations
  • Center for Dermatology Clinical Research Fremont, California, United States
  • International Clinical Research Sanford, Florida, United States
  • Dermatology Consulting Services High Point, North Carolina, United States
  • DermResearch, Inc. Austin, Texas, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

NCT02608450

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • Gary M. Petrus, MD PA Little Rock, Arkansas, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
  • Vitiligo & Pigmentation Institute of Southern California Los Angeles, California, United States
  • San Diego Sports Medicine and Family Health Center San Diego, California, United States
View all 54 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

NCT02608476

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • Clear dermatology & Aesthetic Center Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Center for Dermatology and Laser Surgery Sacramento, California, United States
  • Belleair Research Center Pinellas Park, Florida, United States
View all 52 locations
View Trial Details
Completed

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

NCT02682264

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Gary M. Petrus, MD PA Little Rock, Arkansas, United States
  • Center for Dermatology and Laser Surgery Sacramento, California, United States
  • Rady Childrens Hospital, Pediatric and Adolescent Dermatology San Diego, California, United States
View all 74 locations
View Trial Details
Completed

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

NCT01631474

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • Dermatology Research Associates Los Angeles, California, United States
  • Therapeutics Clinical Research San Diego, California, United States
  • University Clinical Trials San Diego, California, United States
  • International Clinical Research - US, LLC Sanford, Florida, United States
View all 13 locations
View Trial Details
Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

NCT02005666

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • Universal BioPharma Research Dinuba, California, United States
  • Research Across America Santa Ana, California, United States
  • Visions Clinical Research Boynton Beach, Florida, United States
  • Dermatology Research Instititue Coral Gables, Florida, United States
View all 36 locations
View Trial Details

Related conditions